CYP3A variation, premenopausal estrone levels, and breast cancer risk.
about
Candidate gene-environment interactions in breast cancerGenetic variants in hormone-related genes and risk of breast cancer.Tumoral expression of drug and xenobiotic metabolizing enzymes in breast cancer patients of different ethnicities with implications to personalized medicine.Gene-environment dependence creates spurious gene-environment interactionThe role of hormones in the differences in the incidence of breast cancer between Mongolia and the United Kingdom.Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study.Polymorphisms of Phase I and Phase II Enzymes and Breast Cancer Risk.Identification of candidate polymorphisms on stress oxidative and DNA damage repair genes related with clinical outcome in breast cancer patients.Cytochrome P450 Allele CYP3A7*1C Associates with Adverse Outcomes in Chronic Lymphocytic Leukemia, Breast, and Lung Cancer.Common variation of the CYP17 gene in Iraqi women with endometriosis disease.CYP3A7*1C allele is associated with reduced levels of 2-hydroxylation pathway oestrogen metabolites.Genetic polymorphisms of phase I metabolizing enzyme genes, their interaction with lifetime grilled and smoked meat intake, and breast cancer incidence.The expression levels of CYP3A4 and CYP3A5 serve as potential prognostic biomarkers in lung adenocarcinoma.Genetic polymorphisms of lncRNA-p53 regulatory network genes are associated with concurrent chemoradiotherapy toxicities and efficacy in nasopharyngeal carcinoma patients.Unraveling genes, hormones, and breast cancer.Potentially immunogenic proteins expressed similarly in human embryonic stem cells and induced pluripotent stem cells.
P2860
Q26849726-388BE68A-DEEC-4433-8420-73E4A1553BDBQ31126135-CDEAE9AE-D7CE-4363-B806-5CA26F912B8DQ33881477-75DC40D9-339E-4527-AF54-C98B6985DE84Q34146836-F2322B82-5485-43A2-9216-E5E2580C010CQ34764450-88FA37C7-81D6-49A9-9681-C6D7DF888262Q35179897-C8B95EFB-76FA-4773-BE37-8E6CC4F9EBC1Q36429795-17F71CB1-0021-41D5-A325-B33B1D407300Q36538460-CF8FBE21-E1B7-4A98-9B43-577BA311AE2BQ36696957-5294C36D-447C-46D6-8486-2BC12216CCB8Q37485034-70218AC7-28CF-4BD8-9BB5-1F79242C8610Q37627774-5879A3C9-055D-4A31-A46D-84FF559F5172Q37719953-FE9E7625-27EE-4A6F-BDFB-B488B0A1987CQ38851906-D9D71B37-4942-4EA6-B9E6-350301CE653DQ41436597-9F8605D6-3A81-4AFE-B3C8-D76A3690F12DQ43158472-A62C1A20-C1C9-4B49-B74D-A9A807F8A076Q45200161-7CA6C16C-B59B-4430-B93E-5D0FBEEFDAC7
P2860
CYP3A variation, premenopausal estrone levels, and breast cancer risk.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
CYP3A variation, premenopausal estrone levels, and breast cancer risk.
@en
CYP3A variation, premenopausal estrone levels, and breast cancer risk.
@nl
type
label
CYP3A variation, premenopausal estrone levels, and breast cancer risk.
@en
CYP3A variation, premenopausal estrone levels, and breast cancer risk.
@nl
prefLabel
CYP3A variation, premenopausal estrone levels, and breast cancer risk.
@en
CYP3A variation, premenopausal estrone levels, and breast cancer risk.
@nl
P2093
P2860
P50
P356
P1476
CYP3A variation, premenopausal estrone levels, and breast cancer risk.
@en
P2093
Ben Coupland
Ben Haynes
Elizabeth Folkerd
Gemma Simpson
Gillian Ross
Ian P Tomlinson
Jill Williamson
Katarzyna Tomczyk
Kate Walker
Lorna J Gibson
P2860
P304
P356
10.1093/JNCI/DJS156
P407
P50
P577
2012-04-03T00:00:00Z